Mary Jo Brucker

Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.

Robert B. Lobell, CharlesA. Omer, Marc Abrams et al. · PubMed · 2001 · 239 citations

Medicine, Oncology, Pharmacology +16

Concurrent Administration of the Erythromycin Breath Test (EBT) and Oral Midazolam as In Vivo Probes for CYP3A Activity

Jacqueline B. McCrea, Thomayant Prueksaritanont, Barry J. Gertz et al. · The Journal of Clinical Pharmacology · 1999 · 57 citations

Medicine, Pharmacokinetics, Pharmacology +8

Rizatriptan, a Novel 5-HT<SUB>1D/1B</SUB> Agonist for Migraine: Single- and Multiple-Dose Tolerability and Pharmacokinetics in Healthy Subjects

Timothy Olah, Michael R. Goldberg, Y. Lee et al. · The Journal of Clinical Pharmacology · 2000 · 29 citations

Medicine, Pharmacokinetics, Pharmacology +16

Pharmacokinetics of Rizatriptan Tablets During and Between Migraine Attacks

Neal R. Cutler, Stanford S. Jhee, Anup Majumdar et al. · Headache The Journal of Head and Face Pain · 1999 · 28 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +10

Simvastatin Does Not Affect CYP3A Activity, Quantified by the Erythromycin Breath Test and Oral Midazolam Pharmacokinetics, in Healthy Male Subjects

Thomayant Prueksaritanont, José M. Vega, John Rogers et al. · The Journal of Clinical Pharmacology · 2000 · 19 citations

Pharmacy, Pharmacokinetics, Pharmacology +8